Search Results

You are looking at 91 - 100 of 453 items for :

  • "medication" x
Clear All
Restricted access

Declan Ryan, Jorgen Wullems, Georgina Stebbings, Christopher Morse, Claire Stewart and Gladys Onambele-Pearson

Participants arrived for the second laboratory visit in a fasted, hydrated state. Where appropriate, participants were asked to refrain from taking medication until testing had been completed. All participants refrained from taking medication prior to the completion of the laboratory tests. A standardized meal

Restricted access

Marco Van Brussel, Bart C. Bongers, Erik H.J. Hulzebos, Marcella Burghard and Tim Takken

, lung transplantation, chemotherapy)  ▪ Assessment of the efficacy of an surgical correction  ▪ Assessment of the effects of medication on the response to exercise Abbreviations: CPET, cardiopulmonary exercise testing; VO 2max , maximal oxygen uptake; VO 2peak , oxygen uptake at peak exercise. Note: Adapted from

Open access

Sarah Daniels, Gabriela Santiago, Jennifer Cuchna and Bonnie Van Lunen

/17 Conclusion The LITUS device heated tissues at 1.5 and 3.0 cm deep by approximately 3°C–4°C. The LITUS device in conjunction with pain management medication is effective at reducing patients’ chronic trapezius myalgia while producing no reports of negative side effects. Sustained acoustic medicine may be an

Restricted access

Scott J. Dankel, Jeremy P. Loenneke and Paul D. Loprinzi

-reactive protein (continuous; per 1 mg/dL increase), self-reported smoking status (current or former smoker vs never smoked), and the following self-reported conditions (dichotomous): use of ambulatory device, statin medication, arthritis, congestive heart failure, coronary artery disease, cancer, diabetes, and

Full access

Amanda L. Penko, Jacob E. Barkley, Anson B. Rosenfeldt and Jay L. Alberts

assessment, participants were instructed to take their antiparkinsonian medication 1 hour prior to the start of their appointment to ensure evaluations were completed during peak levodopa response. 27 Testing was performed by a single, blinded rater, and PD motor symptoms were assessed utilizing the

Restricted access

Catrine Tudor-Locke, John M. Schuna Jr, Damon L. Swift, Amber T. Dragg, Allison B. Davis, Corby K. Martin, William D. Johnson and Timothy S. Church

(.05/3 = .01667 for each of the 3 possible comparisons). Enrollment targets were set based on an anticipated attrition rate of 15%. Original blood pressure inclusion criteria were as follows: 130 to 179 mm Hg for systolic and 85 to 99 mm Hg for diastolic. Having taken blood pressure–lowering medication

Restricted access

Victor Spiandor Beretta, Fabio Augusto Barbieri, Diego Orcioli-Silva, Paulo Cezar Rocha dos Santos, Lucas Simieli, Rodrigo Vitório and Lilian Teresa Bucken Gobbi

, orthopedic, and/or visual impairments that prevented the subject from performing the required tasks. In addition, only people on PD medication treatment were included. The study was approved by the research ethics committee of the São Paulo State University at Rio Claro, Brazil (no. 52534316

Restricted access

Chantal A. Vella, Erin D. Michos, Dorothy D. Sears, Mary Cushman, Rachel B. Van Hollebeke, Michelle M. Wiest and Matthew A. Allison

 mm Hg or taking antihypertensive medication. Participants self-reported their activity levels using the Typical Week Physical Activity Survey. This survey was adapted from the Cross-Cultural Activity Participation Study 13 and designed to identify the frequency of and time spent in leisure sedentary

Restricted access

Julian A. Owen, Matthew B. Fortes, Saeed Ur Rahman, Mahdi Jibani, Neil P. Walsh and Samuel J. Oliver

when people are ill; take medications (e.g., diuretics); are immersed in water; or exposed to cold and/or hypoxia ( Cheuvront & Kenefick, 2014 ; Cotter et al., 2014 ). Whether hydration markers identify ID or ED is likely to depend on the relationship between the marker and the distinct physiological

Full access

Gregory A. Hand, Robin P. Shook, Daniel P. O’Connor, Madison M. Kindred, Sarah Schumacher, Clemens Drenowatz, Amanda E. Paluch, Stephanie Burgess, John E. Blundell and Steven N. Blair

run-in using SenseWear activity monitor • Planning to participate or currently participating in a weight loss intervention or exercise program • 21–45 y of age • Planning to have weight loss surgery • Fasting plasma glucose <126 mg/dL • Weight change >5 lb in last 12 mo • Current medications must have